CHIR-21208 is a highly selective glycogen synthase kinase-3 (GSK-3) inhibitor. CHIR-21208 is promising for research of neurodegenerative disorders like Alzheimers disease and type 2 diabetes[1].
Molecular Weight:
451.41
CAS Number:
[206275-65-2]
Formula:
C19H20F3N7O3
Target:
GSK-3
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted